"The Lifespan Cancer Institute at Rhode Island Hospital provides the most current cancer diagnosis and treatment options for nearly 40 types of cancer. Cancer treatments include the latest chemotherapy, biologic agents, radiation oncology, surgery, and image-guided procedures—many of which are not available elsewhere in New England. Our world-renowned physicians and specialists form multidisciplinary teams whose collective level of knowledge and experience is unparalleled in the region. We have created a strategic alliance with the Dana-Farber Cancer Institute to advance cancer treatment, enable collabortation on complex cancer cases, coordinate the care of bone marrow transplant patients and expand access to clinical trials."

During the past decade, Rhode Island Hospital Comprehensive Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 24 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rhode Island Hospital Comprehensive Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 17 trials, followed by "Children's Oncology Group" with 17 trials sponsored, "Radiation Therapy Oncology Group" with 5 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored and "Butler Hospital" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rhode Island Hospital Comprehensive Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 47 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator and "American College of Surgeons" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Rhode Island Hospital Comprehensive Cancer Center" are "Lung Cancer" (9 trials), "Leukemia" (8 trials), "Lymphoma" (6 trials), "Brain Tumor" (5 trials) and "Breast Cancer" (5 trials). Many other conditions were trialed in "Rhode Island Hospital Comprehensive Cancer Center" in a lesser frequency.

Most popular intervention types in "Rhode Island Hospital Comprehensive Cancer Center" are "Drug" (30 trials), "Radiation" (16 trials), "Other" (15 trials), "Procedure" (11 trials) and "Biological" (10 trials). Other intervention types were less common.

The name of intervention was led by "etoposide" (10 trials), "cyclophosphamide" (9 trials), "radiation therapy" (9 trials), "cytarabine" (7 trials) and "filgrastim" (7 trials). Other intervention names were less common.

The vast majority of trials in "Rhode Island Hospital Comprehensive Cancer Center" are 42 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Rhode Island Hospital Comprehensive Cancer Center". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Rhode Island Hospital Comprehensive Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Rhode Island Hospital Comprehensive Cancer Center, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".